Reilley, M. J., Morrow, B., Ager, C. R., Liu, A., Hong, D. S., & Curran, M. A. (2019). TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma. J Immunother Cancer.
シカゴスタイル引用形Reilley, Matthew J., Brittany Morrow, Casey R. Ager, Arthur Liu, David S. Hong, , Michael A. Curran. "TLR9 Activation Cooperates With T Cell Checkpoint Blockade to Regress Poorly Immunogenic Melanoma." J Immunother Cancer 2019.
MLA引用形式Reilley, Matthew J., et al. "TLR9 Activation Cooperates With T Cell Checkpoint Blockade to Regress Poorly Immunogenic Melanoma." J Immunother Cancer 2019.
警告: この引用は必ずしも正確ではありません.